These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8798508

  • 21. Differential signal transduction by five splice variants of the PACAP receptor.
    Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L.
    Nature; 1993 Sep 09; 365(6442):170-5. PubMed ID: 8396727
    [Abstract] [Full Text] [Related]

  • 22. Thrombin primes responsiveness of selective chemoattractant receptors at a site distal to G protein activation.
    Ali H, Tomhave ED, Richardson RM, Haribabu B, Snyderman R.
    J Biol Chem; 1996 Feb 09; 271(6):3200-6. PubMed ID: 8621721
    [Abstract] [Full Text] [Related]

  • 23. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
    Hashimoto H, Ogawa N, Hagihara N, Yamamoto K, Imanishi K, Nogi H, Nishino A, Fujita T, Matsuda T, Nagata S, Baba A.
    Mol Pharmacol; 1997 Jul 09; 52(1):128-35. PubMed ID: 9224822
    [Abstract] [Full Text] [Related]

  • 24. Differential signaling and immediate-early gene activation by four splice variants of the human pituitary adenylate cyclase-activating polypeptide receptor (hPACAP-R).
    Pisegna JR, Moody TW, Wank SA.
    Ann N Y Acad Sci; 1996 Dec 26; 805():54-64; discussion 64-6. PubMed ID: 8993393
    [Abstract] [Full Text] [Related]

  • 25. Continuous activation of pituitary adenylate cyclase-activating polypeptide receptors elicits antipodal effects on cyclic AMP and inositol phospholipid signaling pathways in CATH.a cells: role of protein synthesis and protein kinases.
    Muller A, Lutz-Bucher B, Kienlen-Campard P, Koch B, Loeffler JP.
    J Neurochem; 1998 Apr 26; 70(4):1431-40. PubMed ID: 9523559
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 26; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pituitary adenylate cyclase-activating polypeptide activates a phospholipase C-dependent signal pathway in chick ciliary ganglion neurons that selectively inhibits alpha7-containing nicotinic receptors.
    Pardi D, Margiotta JF.
    J Neurosci; 1999 Aug 01; 19(15):6327-37. PubMed ID: 10414962
    [Abstract] [Full Text] [Related]

  • 31. Mutation of an aspartate at position 63 in the human platelet-activating factor receptor augments binding affinity but abolishes G-protein-coupling and inositol phosphate production.
    Parent JL, Le Gouill C, Rola-Pleszczynski M, Stanková J.
    Biochem Biophys Res Commun; 1996 Feb 27; 219(3):968-75. PubMed ID: 8645288
    [Abstract] [Full Text] [Related]

  • 32. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylyl cyclase and phospholipase C activity in rat cerebellar neuroblasts.
    Basille M, Gonzalez BJ, Desrues L, Demas M, Fournier A, Vaudry H.
    J Neurochem; 1995 Sep 27; 65(3):1318-24. PubMed ID: 7643109
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of cytoplasmic tail phosphorylation sites of platelet-activating factor receptor in agonist-induced desensitization.
    Takano T, Honda Z, Sakanaka C, Izumi T, Kameyama K, Haga K, Haga T, Kurokawa K, Shimizu T.
    J Biol Chem; 1994 Sep 02; 269(35):22453-8. PubMed ID: 8071375
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1996 Dec 02; 50(6):1596-604. PubMed ID: 8967982
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor.
    Ogi K, Miyamoto Y, Masuda Y, Habata Y, Hosoya M, Ohtaki T, Masuo Y, Onda H, Fujino M.
    Biochem Biophys Res Commun; 1993 Nov 15; 196(3):1511-21. PubMed ID: 7902709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.